Shilpa med reversed from the support zone, with buying interest in past couple of days. stock is poised for the levels marked as intermediate. However, the stock is expected to take a big breakout above 400 levels.
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在
使用條款閱讀更多資訊。